RxElite

RxElite was a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of generic and branded prescription drugs, primarily for the anesthesia and respiratory markets. The company's product portfolio featured inhalation anesthetics such as sevoflurane and isoflurane, as well as nebulized respiratory medications like albuterol sulfate and ipratropium bromide. RxElite targeted niche markets where it could provide high-quality, cost-effective alternatives to established branded products. Headquartered in Idaho, the company operated manufacturing and distribution facilities to support its commercial operations. In 2009, RxElite's inhalation anesthetic business was acquired by Piramal Healthcare, a move that significantly expanded Piramal's global footprint in the critical care sector.